American Century Companies’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-94,272
Closed -$466K 2943
2025
Q1
$466K Buy
94,272
+720
+0.8% +$2.29K ﹤0.01% 2534
2024
Q4
$275K Buy
93,552
+5,785
+7% +$23.7K ﹤0.01% 2713
2024
Q3
$414K Buy
87,767
+7,814
+10% +$35.2K ﹤0.01% 2536
2024
Q2
$308K Buy
79,953
+11,363
+17% +$51.2K ﹤0.01% 2615
2024
Q1
$367K Buy
68,590
+23,246
+51% +$109K ﹤0.01% 2557
2023
Q4
$194K Buy
45,344
+11,495
+34% +$35.3K ﹤0.01% 2705
2023
Q3
$133K Buy
33,849
+10,825
+47% +$71K ﹤0.01% 2679
2023
Q2
$233K Buy
23,024
+11,744
+104% +$124K ﹤0.01% 2485
2023
Q1
$111K Buy
+11,280
New +$129K ﹤0.01% 2530

Other funds holding TSVT

American Century Companies's TSVT Position: Q2 2025 in Review

American Century Companies sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 94,272 shares — an estimated $466K sold.

American Century Companies first reported a position in TSVT in Q1 2023 and held it in 9 quarters. The position peaked at $466K in Q1 2025. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • American Century Companies reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • American Century Companies sold 94,272 2seventy bio shares in Q2 2025, an estimated $466K.
  • American Century Companies first reported a position in 2seventy bio in Q1 2023 and held it in 9 quarters.
  • American Century Companies's 2seventy bio position peaked at $466K in Q1 2025.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on American Century Companies's 13F filing for Q2 2025, filed 12 Aug 2025.